A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP).

Beggs, P W

A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP). [electronic resource] - British journal of clinical pharmacology Jan 1999 - 99-104 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0306-5251

10.1046/j.1365-2125.1999.00846.x doi


Bezafibrate--adverse effects
Cohort Studies
Comorbidity
Diabetes Complications
Female
Gemfibrozil--adverse effects
Humans
Hypertension--complications
Lipids--blood
Male
Myocardial Ischemia--prevention & control
New Zealand
Practice Patterns, Physicians'
Product Surveillance, Postmarketing--methods
Random Allocation
Retrospective Studies
Risk Factors
Simvastatin--adverse effects
Surveys and Questionnaires
Treatment Outcome